Long before the Supreme Court ruling that upheld the Patient Protection and Affordable Health Care Act, the political battle lines appeared pretty clear. With lobbies like the National Federation of Independent Business (NFIB) acting as plaintiffs in the case, it was easy to assume the business community was solidly aligned in the “against” category on Obamacare, too.
But business reaction has been more mixed, even at the small business level. After all, the legislation addresses much more than the question of whether individuals should be forced to have health insurance. The June 28 decision also upheld a 2.3 percent tax on the revenue of medical device companies. And it offers intellectual property protection that was considered critical by many in the biotechnology sector. So while some see the specter of higher costs, others salivate at the prospect of a wider insured pool that spurs demand for everything from broader hospital services to more mobile health apps.
…
View article:
Obamacare’s Here to Stay. What Do Business Leaders – TodayHeads
Tags: 2.3 percent medical device tax, address, companies, current, device, events, intellectual, medical devices, property, quick draw syringe, result